In many traditional lab organizations, the scientific product development group has historically produced new diagnostic tests without meaningful input and consideration of payer policy and revenue cycle demands. But what if the lab were to begin considering the needs of the revenue cycle even earlier? What if revenue cycle considerations were included in the lab’s decision-making […]
CLEVELAND, January 14, 2019 – Quadax Inc., a healthcare information technology leader in providing revenue cycle optimization software and services, will present strategies for laboratories to improve collections and reduce administrative burden at the 14th Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference West. The conference takes place at the Hilton Garden Inn San Diego Bayside from […]
This white paper is to help clinical laboratory companies successfully implement the new revenue recognition accounting standard – FASB ASC 606.
This white paper is to help organizations that provide and develop diagnostic lab tests understand the need for strong cross-functional collaboration between the revenue cycle and the lab prior to commercialization.
This webinar reviews the principles-based guidelines of ASC 606 and highlights the potential impact within the healthcare industry.
This white paper will provide a guide to implementing a successful prior authorization strategy for clinical laboratories.
Movement continues on CMS reimbursement of Advanced Diagnostic Laboratory Tests (ADLTs) and Molecular Pathology testing during the 14 days following a hospital stay. Recently it was announced that CMS will exercise enforcement discretion until January 2, 2019, for the laboratory date of service (DOS) exception policy for ADLTs and molecular pathology tests excluded from Hospital Outpatient […]
CLEVELAND, Aug. 7, 2018 – At this year’s 2018 Next Generation Dx Summit taking place at the Grand Hyatt Washington from August 20-24, 2018, Quadax will introduce its Prior Authorization Management Service to help laboratory departments streamline the authorization process to grow revenue, decrease claim denials, reduce administrative costs and gain visibility into operational and financial performance. @QuadaxInc […]
How are some of the payers’ Prior Authorization (PA) programs impacting your laboratory’s bottom line and what can you do about it? Increasingly, retroactive authorization after performing lab tests is becoming a less viable option; as is fighting denials for lack of Prior Authorization during the appeal process. While some payers still allow retroactive authorization, […]
Is your cash stranded in the vastness of your lab’s accounts receivable (A/R)? Targeted revenue search and rescue efforts can improve your lab’s financial performance. Know where to send the search party—monitor key performance indicators (KPIs) Days in A/R and Aged A/R. Representing many of the most prominent laboratories in the diagnostic market space, Quadax solves cash flow […]